Evaluation of tolmetin in the treatment of active chronic rheumatoid arthritis open and controlled double-blind studies

Aylward, Mansel, Maddock, J., Parker, R. J., Thomas, Sandra R. and Holly, F. 1976. Evaluation of tolmetin in the treatment of active chronic rheumatoid arthritis open and controlled double-blind studies. Current Medical Research and Opinion 4 (2) , pp. 158-169. 10.1185/03007997609109297

Full text not available from this repository.

Abstract

In a 6-week open study in 24 patients with rheumatoid arthritis, tolmetin was shown to have analgesic and anti-inflammatory activity at daily doses in excess of 1200 mg per day and produced statistically significant reductions in overall joint pain, walking time and articular index. The drug was well tolerated, but 2 patients were withdrawn because of persistent indigestion and 1 because of an urticarial type rash. In a double-blind crossover comparison against indomethacin and placebo in 22 patients, 1400 mg tolmetin daily showed efficacy comparable with that of 150 mg indomethacin daily. Few side-effects were reported and did not necessitate any patients being withdrawn.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	arthritis, rheumatoid, tolmetin, indomethacin, anti-inflammatory agents
Publisher:	Informa Healthcare
ISSN:	0300-7995
Last Modified:	04 Jun 2017 04:18
URI:	https://orca.cardiff.ac.uk/id/eprint/36570

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item